News for Global Health Limited (GLH.AX)

Discover three exciting ASX-listed growth companies – ResMed, GenTrack, and Pinnacle Investment – and learn how each business is shaping the future with innovative solutions and long-term potential.

PR NewswirePERTH, Australia, March 16, 2025 PERTH, Australia, March 16, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF), a clinical-st

TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. (”œBlue Moon”) (TSXV: MOON), Nussir ASA (”œNussir”) and Nye Sulitjelma Gruver AS (”œNS

**media[550524]**

Australian X-ray technology company Micro-X will develop a world-first full-body mobile CT following the award of an up to US$16.4m (A$25m) development contrac

**media[521488]**

Which sector of the ASX is flying under the radar, yet may be full of potential? If you said Healthcare, you’re on the right track.

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.

SYDNEY, Sept. 26, 2024 /PRNewswire/ -- Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial health solutions, today announced the publication of a peer-reviewed study validating its innovative method for measuring central aortic pressure-an important indicator of heart health-using a noninvasive fingertip sensor. The study, co-authored by Cardiex's team, was published in the respected journal Pulse.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Aussie markets have somehow pulled of a miracle gain despite two horror sessions this week.

Recce Pharmaceuticals Reports Positive Preclinical Data of RECCE ® 327 in Lung Infection Pilot Study

Certain Equity Shares of Global Health Limited are subject to a Lock-Up Agreement Ending on 13-MAY-2024. These Equity Shares will be under lockup for 551 days starting from 9-NOV-2022 to...

Telix Pharmaceuticals Limited completes the acquisition of AR™S, Inc.

Recce Pharmaceuticals Selected by UK Government Innovation Agency to Participate in AMR Mission 2024

In this article, we will be taking a look at the 20 biggest health care companies in Australia, 2024.

Nifty futures on the NSE International Exchange traded 4 points, or 0.02 per cent, lower at 22,051, hinting at a flattish start for the domestic market on Thursday.

Dayforce® recurring revenue of $292.1 million, up 30.1% year-over-year in the fourth quarter, or 29.9% on a constant currency basis Total revenue of...

The ASX200 finished off the first day of December down 0.2 of a percent - with all sectors, except energy, losing some ground.